AXODOX 50 D/S
CEPODOXIME 50 MG D/S
Brand: AXODOX 50 D/S
MRP
₹90/-
Packaging
30 ML GLASS BOTTLE WITH WATER
Form
ANTIBIOTIC
Description & Usage
Cefpodoxime 50 MG D/S
Cefpodoxime 50 MG D/S is a type of pharmaceutical dry syrup which uses Cefpodoxime as the primary active ingredient. The drug falls under the cephalosporin category and is commonly seen in the antibiotic segment of various pharmaceutical companies. The 50 mg dry syrup strength is normally kept within product portfolios that aim at general medicine and pediatric doses.
This formulation is supplied in dry syrup form; hence, it can be easily packaged, stored, transported and delivered. Cefpodoxime 50 MG D/S enjoys market value since dry syrup formations have their place within the pharmaceutical business. Whichever company is doing PCD pharma franchise, third party manufacturing or marketing branded medicines usually adds this composition in their list of products to make their catalog stronger.
Composition Profile And Dry Syrup Strength
A single dry syrup dosage unit of Cefpodoxime 50 MG D/S contain 50mg as the active pharmaceutical ingredient while the other constituents being excipients, suspending agents, sweetening agents and flavoring agents. The formulation receives the 50 mg identity due to the specific amount of Cefpodoxime it carries which defines a product identity among other dry syrup product strengths.
A well-engineered Cefpodoxime 50 MG D/S dry syrup formation is known for its steady powder quality, smooth suspension quality, as well as accurate consistency after formulation. Since this form needs to be stored prior to constitution, the structure and composition are carefully managed in the product itself. The drug is sensitive to changes, especially to environmental factors.
Quality Manufacturing And Processing Standards
The manufacture of Cefpodoxime 50 MG D/S must follow the established quality standards and hygienic production practices. Reputable manufacturers adhere to Good Manufacturing Practices (GMP) to achieve high quality and stability of their products. High quality raw materials and modern equipment are used in its manufacturing process. All steps of manufacturing are carefully handled to guarantee good product quality.
Different quality tests are carried out at various stages during production, for instance testing of the raw material at the time of procurement, visual checks of blended powder for homogeneity, moisture analysis, and final product quality check before dispatch. Controlled conditions are of utmost importance during its formulation due to the susceptibility of dry syrup products to the surrounding atmosphere and humidity.
Packaging, Labeling And Product Presentation
Packaging of the Cefpodoxime 50 MG D/S formulation needs to be done efficiently and carefully to protect the powder form of the drug from moisture and other contaminants, as well as to provide an aesthetic and clear presentation. High quality packaging of dry syrup usually comprises of a sturdy bottle that has a perfectly fitted and secure cap. It also typically includes an attractive outer carton.
The label on the Cefpodoxime 50 MG D/S product packaging should contain adequate details about the composition. These details typically include the brand name of the medicine, the chemical name of the active pharmaceutical ingredient, its strength, the quantity, batch number, date of manufacturing and expiry, maximum retail price, storage guidelines, and manufacturing company. The label should clearly state how the drug is intended to be used once reconstituted.
Market Demand And Business Importance
Cefpodoxime 50 MG D/S has a substantial demand in the market as it is a critical component of the ranges that many pharma companies produce. A formulation like this is an ideal complement to an already existing Cefpodoxime formulation of higher strength or tablet forms, to build a stronger product range with various options.
Wholesalers and distributors looking to strengthen their antibiotic or pediatric category by adding the dry syrup form of a leading antibiotic usually rely on 50 mg dosage for better versatility. It may prove useful for pharma franchise holders that want to be better equipped for market demands. With consistent supply, market presence, and appropriate quality, the Cefpodoxime 50 MG D/S product has the ability to support growing business opportunities in the pharma domain.
PCD Pharma Franchise Scope
Cefpodoxime 50 MG D/S represents an opportunity for PCD pharma franchise businesses as well, since dry syrup formulation has demand and the active pharmaceutical ingredient is a leading antibiotic among a vast number of indications. Companies have the capacity to support franchise business owners by providing promotional inputs that can be used by their marketing teams on field and as general advertisements.
For franchise distributors of medicines, the Cefpodoxime 50 MG D/S formulation could be a value-addition to their catalog, particularly when supplied with assured quality. A good PCD pharma franchise company would support its clients with strong branding and effective distribution network to support the market demand for Cefpodoxime 50 MG D/S.
Cefpodoxime 50 MG D/S
Cefpodoxime 50 MG D/S is a type of pharmaceutical dry syrup which uses Cefpodoxime as the primary active ingredient. The drug falls under the cephalosporin category and is commonly seen in the antibiotic segment of various pharmaceutical companies. The 50 mg dry syrup strength is normally kept within product portfolios that aim at general medicine and pediatric doses.
This formulation is supplied in dry syrup form; hence, it can be easily packaged, stored, transported and delivered. Cefpodoxime 50 MG D/S enjoys market value since dry syrup formations have their place within the pharmaceutical business. Whichever company is doing PCD pharma franchise, third party manufacturing or marketing branded medicines usually adds this composition in their list of products to make their catalog stronger.
Composition Profile And Dry Syrup Strength
A single dry syrup dosage unit of Cefpodoxime 50 MG D/S contain 50mg as the active pharmaceutical ingredient while the other constituents being excipients, suspending agents, sweetening agents and flavoring agents. The formulation receives the 50 mg identity due to the specific amount of Cefpodoxime it carries which defines a product identity among other dry syrup product strengths.
A well-engineered Cefpodoxime 50 MG D/S dry syrup formation is known for its steady powder quality, smooth suspension quality, as well as accurate consistency after formulation. Since this form needs to be stored prior to constitution, the structure and composition are carefully managed in the product itself. The drug is sensitive to changes, especially to environmental factors.
Quality Manufacturing And Processing Standards
The manufacture of Cefpodoxime 50 MG D/S must follow the established quality standards and hygienic production practices. Reputable manufacturers adhere to Good Manufacturing Practices (GMP) to achieve high quality and stability of their products. High quality raw materials and modern equipment are used in its manufacturing process. All steps of manufacturing are carefully handled to guarantee good product quality.
Different quality tests are carried out at various stages during production, for instance testing of the raw material at the time of procurement, visual checks of blended powder for homogeneity, moisture analysis, and final product quality check before dispatch. Controlled conditions are of utmost importance during its formulation due to the susceptibility of dry syrup products to the surrounding atmosphere and humidity.
Packaging, Labeling And Product Presentation
Packaging of the Cefpodoxime 50 MG D/S formulation needs to be done efficiently and carefully to protect the powder form of the drug from moisture and other contaminants, as well as to provide an aesthetic and clear presentation. High quality packaging of dry syrup usually comprises of a sturdy bottle that has a perfectly fitted and secure cap. It also typically includes an attractive outer carton.
The label on the Cefpodoxime 50 MG D/S product packaging should contain adequate details about the composition. These details typically include the brand name of the medicine, the chemical name of the active pharmaceutical ingredient, its strength, the quantity, batch number, date of manufacturing and expiry, maximum retail price, storage guidelines, and manufacturing company. The label should clearly state how the drug is intended to be used once reconstituted.
Market Demand And Business Importance
Cefpodoxime 50 MG D/S has a substantial demand in the market as it is a critical component of the ranges that many pharma companies produce. A formulation like this is an ideal complement to an already existing Cefpodoxime formulation of higher strength or tablet forms, to build a stronger product range with various options.
Wholesalers and distributors looking to strengthen their antibiotic or pediatric category by adding the dry syrup form of a leading antibiotic usually rely on 50 mg dosage for better versatility. It may prove useful for pharma franchise holders that want to be better equipped for market demands. With consistent supply, market presence, and appropriate quality, the Cefpodoxime 50 MG D/S product has the ability to support growing business opportunities in the pharma domain.
PCD Pharma Franchise Scope
Cefpodoxime 50 MG D/S represents an opportunity for PCD pharma franchise businesses as well, since dry syrup formulation has demand and the active pharmaceutical ingredient is a leading antibiotic among a vast number of indications. Companies have the capacity to support franchise business owners by providing promotional inputs that can be used by their marketing teams on field and as general advertisements.
For franchise distributors of medicines, the Cefpodoxime 50 MG D/S formulation could be a value-addition to their catalog, particularly when supplied with assured quality. A good PCD pharma franchise company would support its clients with strong branding and effective distribution network to support the market demand for Cefpodoxime 50 MG D/S.